Stay updated on Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small version update that does not modify the study details.SummaryDifference0.1%

- Check8 days agoChange DetectedFooter revision tag updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status is updated to indicate the study is no longer recruiting, and the page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating formatting for Intervention/Treatment and the Revision note to v3.6.0.SummaryDifference0.4%

- Check30 days agoChange DetectedA new revision label v3.5.5 appears in the page footer, replacing the previous v3.5.4.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the page was released. The update is likely to include minor edits to metadata or formatting rather than substantive changes to the study details.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision tag was updated from v3.5.2 to v3.5.3. This reflects a minor metadata update to the ClinicalTrials.gov page without changing the study content.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.